The growing
geriatric population and increasing demand of innovative and advanced pain
relaxing medications around the world are the predominant growth drivers for
the global pain
management drugs market. Additionally, the increasing number of
hospitalization cases; unmet requirements for neuropathic pain management
drugs; innovative and advanced applications of pain management therapies;
increasing prevalence of various chronic diseases, such as cancer, and
neurological problems; and increasing healthcare expenditure are also driving
the growth of the global market. The growing numbers of mergers and
acquisitions is a key trend observed in the market. Among the various
therapeutic indications, the post-operative pain relief segment accounted for
the largest share, and the low-back pain segment accounted for the second
largest share in the global market.
Pain
management drugs are mainly used to relieve discomfort associated with injury
and surgeries. Moreover, pain management medications are used in the management
of pain associated with neurological problems, migraine, cancer, orthopedic
problems, low- back pain, rheumatoid arthritis, and fibromyalgia.
Request to Get the
Sample Pages at:
North
America and Europe are the major markets, due to increasing prevalence of
chronic diseases, and growing awareness about various types of chronic pain
conditions in these regions. The U.S. followed by Canada, is the largest market
for pain management drugs in North America. Whereas, the U.K., Germany and
France are some of the major countries holding significant share in the
European pain management drugs market.
The Asian
market is growing with a significant rate, owing to huge pool of patients, and
increasing healthcare spending in the region. In addition, the initiatives
taken by various government associations to develop chronic pain rehabilitation
centers, and increasing prevalence of various chronic diseases are also
supporting the growth of the Asian pain management drugs market. The countries
such as India, Japan and China, are the major markets in the region.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=pain-management-drugs-market
Apart from
these regions, Latin America is another important market. This is due to
increasing investments by drug manufacturing companies and growing demand of
pain management medications in the region. Brazil holds the largest share in
the Latin American pain management drugs market, due to the increasing support
from government organizations for the development of chronic pain
rehabilitation center in the country.
Some of the
major players operating in the global pain management drugs market include
Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company,
Forest Laboratories Inc., Endo International PLC, Johnson & Johnson, Pfizer
Inc., Valeant Pharmaceuticals International Inc., GlaxoSmithKline PLC, F.
Hoffmann-La Roche Ltd., and Baxter International Inc.
Pain
Management Drugs Market Segmentation
By Category
• Prescription-Based Drugs
• Over-The-Counter (OTC) Drugs
By
Therapeutic Indications
• Post-Operative Pain
• Low-Back Pain
• Rheumatoid Arthritis Pain
• Osteoarthritis Pain
• Cancer Pain
• Migraine
• Neuropathic Pain
• Fibromyalgia
• Others
By Brands
• Maxalt
• Zomig
• Qutenza
• Lidoderm
• Savella
• Imitrex
• Voltaren Gel
• Celebrex
• Cymbalta
• Others
By
Geography
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o U.K.
o Spain
o Italy
• Asia
o Japan
o China
o India
• Latin America
o Brazil
• Rest of the World
